Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Peptide Therapeutics Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Ipsen
5.1.1 Ipsen Company Profile
5.1.2 Ipsen Business Overview
5.1.3 Ipsen Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Ipsen Peptide Therapeutics Products Introduction
5.2 Amgen
5.2.1 Amgen Company Profile
5.2.2 Amgen Business Overview
5.2.3 Amgen Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Amgen Peptide Therapeutics Products Introduction
5.3 Merck
5.3.1 Merck Company Profile
5.3.2 Merck Business Overview
5.3.3 Merck Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Merck Peptide Therapeutics Products Introduction
5.4 Novo Nordisk
5.4.1 Novo Nordisk Company Profile
5.4.2 Novo Nordisk Business Overview
5.4.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Novo Nordisk Peptide Therapeutics Products Introduction
5.5 CordenPharma
5.5.1 CordenPharma Company Profile
5.5.2 CordenPharma Business Overview
5.5.3 CordenPharma Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 CordenPharma Peptide Therapeutics Products Introduction
5.6 Teva
5.6.1 Teva Company Profile
5.6.2 Teva Business Overview
5.6.3 Teva Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Teva Peptide Therapeutics Products Introduction
5.7 PolyPeptide Group
5.7.1 PolyPeptide Group Company Profile
5.7.2 PolyPeptide Group Business Overview
5.7.3 PolyPeptide Group Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 PolyPeptide Group Peptide Therapeutics Products Introduction
5.8 Eli Lilly
5.8.1 Eli Lilly Company Profile
5.8.2 Eli Lilly Business Overview
5.8.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Eli Lilly Peptide Therapeutics Products Introduction
5.9 Roche
5.9.1 Roche Company Profile
5.9.2 Roche Business Overview
5.9.3 Roche Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Roche Peptide Therapeutics Products Introduction
5.10 AstraZeneca
5.10.1 AstraZeneca Company Profile
5.10.2 AstraZeneca Business Overview
5.10.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 AstraZeneca Peptide Therapeutics Products Introduction
5.11 Lonza
5.11.1 Lonza Company Profile
5.11.2 Lonza Business Overview
5.11.3 Lonza Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Lonza Peptide Therapeutics Products Introduction
5.12 Bachem
5.12.1 Bachem Company Profile
5.12.2 Bachem Business Overview
5.12.3 Bachem Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Bachem Peptide Therapeutics Products Introduction
5.13 Takeda Pharmaceutical
5.13.1 Takeda Pharmaceutical Company Profile
5.13.2 Takeda Pharmaceutical Business Overview
5.13.3 Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Takeda Pharmaceutical Peptide Therapeutics Products Introduction
5.14 Novartis
5.14.1 Novartis Company Profile
5.14.2 Novartis Business Overview
5.14.3 Novartis Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Novartis Peptide Therapeutics Products Introduction
5.15 Sanofi
5.15.1 Sanofi Company Profile
5.15.2 Sanofi Business Overview
5.15.3 Sanofi Peptide Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Sanofi Peptide Therapeutics Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Peptide Therapeutics Sales and Market Share by Types (2015-2020)
6.1.2 Global Peptide Therapeutics Revenue and Market Share by Types (2015-2020)
6.1.3 Global Peptide Therapeutics Price by Types (2015-2020)
6.2 Global Peptide Therapeutics Market Forecast by Types (2020-2025)
6.2.1 Global Peptide Therapeutics Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Peptide Therapeutics Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Peptide Therapeutics Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Peptide Therapeutics Sales, Price and Growth Rate of Generic Drugs
6.3.2 Global Peptide Therapeutics Sales, Price and Growth Rate of Branded Drugs
6.3.3 Global Peptide Therapeutics Sales, Price and Growth Rate of Others
6.4 Global Peptide Therapeutics Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Generic Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.2 Branded Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.3 Others Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Peptide Therapeutics Sales and Market Share by Applications (2015-2020)
7.1.2 Global Peptide Therapeutics Revenue and Market Share by Applications (2015-2020)
7.2 Global Peptide Therapeutics Market Forecast by Applications (2020-2025)
7.2.1 Global Peptide Therapeutics Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Peptide Therapeutics Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Cancer (2015-2020)
7.3.2 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Cardiovascular (2015-2020)
7.3.3 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Central Nervous System (2015-2020)
7.3.4 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Metabolic Disorders (2015-2020)
7.3.5 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Infection (2015-2020)
7.3.6 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Hematological Disorders (2015-2020)
7.3.7 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Gastrointestinal Disorders (2015-2020)
7.3.8 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Respiratory Disorders (2015-2020)
7.3.9 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Acromegaly (2015-2020)
7.3.10 Global Peptide Therapeutics Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Peptide Therapeutics Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.2 Cardiovascular Market Revenue and Sales Forecast (2020-2025)
7.4.3 Central Nervous System Market Revenue and Sales Forecast (2020-2025)
7.4.4 Metabolic Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.5 Infection Market Revenue and Sales Forecast (2020-2025)
7.4.6 Hematological Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.7 Gastrointestinal Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.8 Respiratory Disorders Market Revenue and Sales Forecast (2020-2025)
7.4.9 Acromegaly Market Revenue and Sales Forecast (2020-2025)
7.4.10 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Peptide Therapeutics Sales by Regions (2015-2020)
8.2 Global Peptide Therapeutics Market Revenue by Regions (2015-2020)
8.3 Global Peptide Therapeutics Market Forecast by Regions (2020-2025)

9 North America Peptide Therapeutics Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Peptide Therapeutics Market Sales and Growth Rate (2015-2020)
9.3 North America Peptide Therapeutics Market Revenue and Growth Rate (2015-2020)
9.4 North America Peptide Therapeutics Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Peptide Therapeutics Market Analysis by Country
9.6.1 U.S. Peptide Therapeutics Sales and Growth Rate
9.6.2 Canada Peptide Therapeutics Sales and Growth Rate
9.6.3 Mexico Peptide Therapeutics Sales and Growth Rate

10 Europe Peptide Therapeutics Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Peptide Therapeutics Market Sales and Growth Rate (2015-2020)
10.3 Europe Peptide Therapeutics Market Revenue and Growth Rate (2015-2020)
10.4 Europe Peptide Therapeutics Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Peptide Therapeutics Market Analysis by Country
10.6.1 Germany Peptide Therapeutics Sales and Growth Rate
10.6.2 United Kingdom Peptide Therapeutics Sales and Growth Rate
10.6.3 France Peptide Therapeutics Sales and Growth Rate
10.6.4 Italy Peptide Therapeutics Sales and Growth Rate
10.6.5 Spain Peptide Therapeutics Sales and Growth Rate
10.6.6 Russia Peptide Therapeutics Sales and Growth Rate

11 Asia-Pacific Peptide Therapeutics Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Peptide Therapeutics Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Peptide Therapeutics Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Peptide Therapeutics Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Peptide Therapeutics Market Analysis by Country
11.6.1 China Peptide Therapeutics Sales and Growth Rate
11.6.2 Japan Peptide Therapeutics Sales and Growth Rate
11.6.3 South Korea Peptide Therapeutics Sales and Growth Rate
11.6.4 Australia Peptide Therapeutics Sales and Growth Rate
11.6.5 India Peptide Therapeutics Sales and Growth Rate

12 South America Peptide Therapeutics Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Peptide Therapeutics Market Sales and Growth Rate (2015-2020)
12.3 South America Peptide Therapeutics Market Revenue and Growth Rate (2015-2020)
12.4 South America Peptide Therapeutics Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Peptide Therapeutics Market Analysis by Country
12.6.1 Brazil Peptide Therapeutics Sales and Growth Rate
12.6.2 Argentina Peptide Therapeutics Sales and Growth Rate
12.6.3 Columbia Peptide Therapeutics Sales and Growth Rate

13 Middle East and Africa Peptide Therapeutics Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Peptide Therapeutics Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Peptide Therapeutics Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Peptide Therapeutics Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Peptide Therapeutics Market Analysis by Country
13.6.1 UAE Peptide Therapeutics Sales and Growth Rate
13.6.2 Egypt Peptide Therapeutics Sales and Growth Rate
13.6.3 South Africa Peptide Therapeutics Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source